Johnson & Johnson
JNJ
#10
Rank
$483.57 B
Marketcap
$155.00
Share price
1.02%
Change (1 day)
-13.01%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

P/E ratio for Johnson & Johnson (JNJ)

P/E ratio as of April 2023 (TTM): 22.7

According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.6885. At the end of 2021 the company had a P/E ratio of 21.6.

P/E ratio history for Johnson & Johnson from 2001 to 2022

PE ratio at the end of each year

Year P/E ratio Change
202121.6-23.35%
202028.233.07%
201921.2-6.74%
201822.7-92.46%
20173011460.23%
201619.34.46%
201518.52.49%
201418.0-3.32%
201318.64.62%
201217.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
28.8 27.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
7.28-67.92%๐Ÿ‡บ๐Ÿ‡ธ USA
23.6 3.92%๐Ÿ‡บ๐Ÿ‡ธ USA
26.4 16.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
51.2 125.54%๐Ÿ‡บ๐Ÿ‡ธ USA
19.1-15.70%๐Ÿ‡ซ๐Ÿ‡ท France
22.6-0.37%๐Ÿ‡บ๐Ÿ‡ธ USA
45.8 101.72%๐Ÿ‡บ๐Ÿ‡ธ USA
18.6-18.19%๐Ÿ‡บ๐Ÿ‡ธ USA
4.50-80.18%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.